Name: Clinical response to treatment of HIV-positive patients with lymphoma (en Inglés)
Price: 172266.00 COP
Availability: InStock
Author: Ferreira Gomes, Carolina ; Pochmann Zambonato, Bruna ; Pezzi, Annelise
ISBN: 9786207005536

portada Clinical response to treatment of HIV-positive patients with lymphoma (en Inglés)

Clinical response to treatment of HIV-positive patients with lymphoma (en Inglés)

Formato

Libro Físico

Autor

Annelise Pezzi

Carolina Ferreira Gomes

Bruna Pochmann Zambonato

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.10 kg.

ISBN13

9786207005536

Categorías

Medicina: cuestiones generales

Clinical response to treatment of HIV-positive patients with lymphoma (en Inglés)

Annelise Pezzi (Autor) · Carolina Ferreira Gomes (Autor) · Bruna Pochmann Zambonato (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 20 a 24 días háb.

$ 344.532$ 172.266

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 172.266

¡Envío Gratis! Llega entre el 21 Ago y el 28 Ago a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Clinical response to treatment of HIV-positive patients with lymphoma (en Inglés)"

The Human Immunodeficiency Virus (HIV) is one of the most common sexually transmitted diseases (STDs) today and has the highest transmission rates. Infected people have an increased risk of developing certain types of lymphoma. The prognosis of these patients is mainly related to the lymphoma, the patient and the HIV infection. Treatment for HIV with antiretroviral therapy (ART) has led to an increase in the survival of these patients. Due to the good evolution of treatment in HIV-positive patients, it has been possible to treat lymphomas related to the disease using standard chemotherapy. However, in Brazil, the use of Rituximab is not yet permitted by the Unified Health System. This could end up affecting the quality and survival of these patients. The aim of the study was to characterize the population, their treatments and clinical responses to the treatment made available by the SUS.